Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: Cholecystokinin and gastrin peptides

Acta Physiologica

Volumn 201, Issue 4, 2011, Pages 405-411

  Rehfeld, J F ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cholecystokinin; Gastrin; Glucagon like peptide 1; Glucose dependent insulinotropic polypeptide; Incretin; Insulin

Indexed keywords

CHOLECYSTOKININ; GASTRIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN;

BETA RHYTHM; CELL GROWTH; COMPARATIVE STUDY; DIABETES MELLITUS; GALLBLADDER EMPTYING; GASTRIN RELEASE; GLUCAGON RELEASE; GLUCOSE TOLERANCE TEST; HORMONE ACTION; HUMAN; HYPERGASTRINEMIA; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET CELL HYPERPLASIA; PRIORITY JOURNAL; RESEARCH; REVIEW; STATISTICAL SIGNIFICANCE; STOMACH ACID SECRETION; STOMACH SECRETION;

ANIMALS; CHOLECYSTOKININ; GASTRIC INHIBITORY POLYPEPTIDE; GASTRINS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INCRETINS; PEPTIDES; RECEPTORS, GASTROINTESTINAL HORMONE;

EID: 79952512270     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2010.02235.x     Document Type: Review

References (73)

1. Ahrén, B., Martensson, H. & Nobin, A. 1988. Cholecystokinin (CCK)-4 and CCK-8 stimulate islet hormone secretion in vivo in the pig. Pancreas 3, 279-284.
2. Bani, S.T., Bani, D. & Biliotti, G. 1985. Nesidioblastosis and islet cell changes related to endogenous hypergastrinemia. Virchows Arch B Cell Pathol Incl Mol Pathol 48, 261-276.
3. Bardram, L. 1990. Gastrin in non-neoplastic pancreatic tissue from patients with and without gastrinomas. Scand J Gastroenterol 25, 935-943.
4. Bardram, L., Hilsted, L. & Rehfeld, J.F. 1990. Progastrin expression in mammalian pancreas. Proc Natl Acad Sci USA 87, 298-302.
5. Bayliss, W.M. & Starling, E.H. 1902. The mechanism of pancreatic secretion. J Physiol 28, 325-353.
6. Blonde, L., Klein, E.J., Han, J., Zhang, B., Mac, S.M., Poon, T.H., Taylor, K.L., Trautmann, M.E., Kim, D.D. & Kendall, D.M. 2006. Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82weeks in 314 overweight patients with type 2 diabetes. Diabetes Obes Metab 8, 436-447.
7. Brand, S.J., Andersen, B.N. & Rehfeld, J.F. 1984. Complete tyrosine-O-sulphation of gastrin in neonatal rat pancreas. Nature 309, 456-458.
8. Brand, S.J., Tagerud, S., Lambert, P., Magil, S.G., Tatarkiewicz, K., Doiron, K. & Yan, Y. 2002. Pharmacological treatment of chronic diabetes by stimulating pancreatic beta-cell regeneration with systemic co-administration of EGF and gastrin. Pharmacol Toxicol 91, 414-420.
9. Cantor, P., Andersen, B.N. & Rehfeld, J.F. 1986. Complete tyrosine O-sulfation of gastrin in adult and neonatal cat pancreas. FEBS Lett 195, 272-274.
10. Chen, D., Zhao, C.M., Yamada, H., Norlen, P. & Håkanson, R. 1998. Novel aspects of gastrin-induced activation of histidine decarboxylase in rat stomach ECL cells. Regul Pept 77, 169-175.
11. Chen, D., Zhao, C.M., Håkanson, R., Samuelson, L.C., Rehfeld, J.F. & Friis-Hansen, L. 2004. Altered control of gastric acid secretion in gastrin-cholecystokinin double mutant mice. Gastroenterology 126, 476-487.
12. Chia, W.C. & Egan, J.M. 2008. Incretin-based therapies in type 2 diabetes mellitus. J Clin Endocrinol Metab 93, 3703-3716.
13. Creutzfeldt, W. 2005. The (pre-)history of the incretin concept. Regul Pept 128, 87-91.
14. Degn, K.B., Juhl, C.B., Sturis, J., Jakobsen, G., Brock, B., Chandramouli, V., Rungby, J., Landau, B.R. & Schmitz, O. 2004. One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes. Diabetes 53, 1187-1194.
15. Dockray, G.J., Gregory, R.A., Hutchison, J.B., Harris, J.I. & Runswick, M.J. 1978. Isolation, structure and biological activity of two cholecystokinin octapeptides from sheep brain. Nature 274, 711-713.
16. Drucker, D.J. 2006. The biology of incretin hormones. Cell Metab 3, 153-165.
17. Dufresne, M., Seva, C. & Fourmy, D. 2006. Cholecystokinin and gastrin receptors. Physiol Rev 86, 805-847.
18. Dupre, J., Curtis, J.D., Unger, R.H., Waddell, R.W. & Beck, J.C. 1969. Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man. J Clin Invest 48, 745-757.
19. Elrick, H., Stimmler, L., Hlad, C.J. & Arai, Y. 1964. Plasma insulin responses to oral and intravenous glucose administration. J Clin Endocrinol Metab 24, 1076-1082.
20. Gregory, R.A. & Tracy, H.J. 1972. Isolation of two "big gastrins" from Zollinger-Ellison tumour tissue. Lancet 2, 797-799.
21. Gregory, H., Hardy, P.M., Jones, D.S., Kenner, G.W. & Sheppard, R.C. 1964. The antral hormone gastrin. Structure of gastrin. Nature 204, 931-933.
22. Gregory, R.A., Tracy, H.J., Harris, J.I., Runswick, M.J., Moore, S., Kenner, G.W. & Ramage, R. 1979. Minigastrin; corrected structure and synthesis. Hoppe Seylers Z Physiol Chem 360, 73-80.
23. Holst, J.J. 2007. The physiology of glucagon-like peptide 1. Physiol Rev 87, 1409-1439.
24. Honda, T., Wada, E., Battey, J.F. & Wank, S.A. 1993. Differential gene expression of CCK(A) and CCK(B) receptors in the rat brain. Mol Cell Neurosci 4, 143-154.
25. Johnson, L.R. 1976. The trophic action of gastrointestinal hormones. Gastroenterology 70, 278-288.
26. Johnson, L.R., Aures, D. & Håkanson, R. 1969. Effect of gastrin on the in vivo incorporation of 14C-leucine into protein of the digestive tract. Proc Soc Exp Biol Med 132, 996-998.
27. Kaneto, A., Tasaka, Y., Kosaka, K. & Nakao, K. 1969. Stimulation of insulin secretion by the C-terminal tetrapeptide amide of gastrin. Endocrinology 84, 1098-1106.
28. Kieffer, T.J. 2004. Gastro-intestinal hormones GIP and GLP-1. Ann Endocrinol (Paris) 65, 13-21.
29. Kopin, A.S., Lee, Y.M., McBride, E.W., Miller, L.J., Lu, M., Lin, H.Y., Kolakowski, L.F. Jr & Beinborn, M. 1992. Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA 89, 3605-3609.
30. La Barre, J. 1932. Sur le possibilité d'un traitement du diabète par l'incrétine. Bull Acad R Med Belg 12, 620-634.
31. La Barre, J. & Still, E.U. 1930. Studies on the physiology of secretin. Am J Physiol 91, 649-653.
32. Larsson, L.I. & Rehfeld, J.F. 1979a. Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system. Brain Res 165, 201-218.
33. Larsson, L.I. & Rehfeld, J.F. 1979b. Peptidergic and adrenergic innervation of pancreatic ganglia. Scand J Gastroenterol 14, 433-437.
34. Larsson, L.I., Ljungberg, O., Sundler, F., Håkanson, R., Svensson, S.O., Rehfeld, J., Stadil, R. & Holst, J. 1973. Antro-pyloric gastrinoma associated with pancreatic nesidioblastosis and proliferation of islets. Virchows Arch A Pathol Pathol Anat 360, 305-314.
35. Larsson, L.I., Rehfeld, J.F., Sundler, F. & Håkanson, R. 1976. Pancreatic gastrin in foetal and neonatal rats. Nature 262, 609-610.
36. Larsson, L.I., Goltermann, N.R., de Magistris, L., Rehfeld, J.F. & Schwartz, T.W. 1979. Somatostatin cell processes as pathways for paracrine secretion. Science 205, 1393-1395.
37. Lee, Y.M., Beinborn, M., McBride, E.W., Lu, M., Kolakowski, L.F. Jr & Kopin, A.S. 1993. The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. J Biol Chem 268, 8164-8169.
38. Loew, E.R., Gray, J.S. & Ivy, A.C. 1939. The effect of duodenal instillation of hydrochloric acid upon fasting blood sugar of dogs. Am J Physiol 126, 270-276.
39. Loew, E.R., Gray, J.S. & Ivy, A.C. 1940a. The effect of acid stimulation of the duodenum upon experimental hyperglycemia and utilization of glucose. Am J Physiol 128, 298-308.
40. Loew, E.R., Gray, J.S. & Ivy, A.C. 1940b. Is a duodenal hormone involved in carbohydrate metabolism? Am J Physiol 129, 659-663.
41. McIntyre, N., Holdsworth, C.D. & Turner, D.A. 1964. New interpretation of oral glucose tolerance. Lancet II, 20-21.
42. Moore, B., Edie, E.S. & Abram, J.H. 1906. On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane. Biochem J 1, 28-38.
43. Ohgawara, H., Mizuno, Y., Tasaka, Y. & Kosaka, K. 1969. Effect of the C-terminal tetrapeptide amide of gastrin on insulin secretion in man. J Clin Endocrinol Metab 29, 1261-1262.
44. Rehfeld, J.F. 1971. Effect of gastrin and its C-terminal tetrapeptide on insulin secretion in man. Acta Endocrinol (Copenh) 66, 169-176.
45. Rehfeld, J.F. 1976. Disturbed islet-cell function related to endogenous gastrin release. Studies on insulin secretion and glucose tolerance in pernicious anemia. J Clin Invest 58, 41-49.
46. Rehfeld, J.F. 1978. Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. J Biol Chem 253, 4022-4030.
47. Rehfeld, J.F. 1998a. How to measure cholecystokinin in tissue, plasma and cerebrospinal fluid. Regul Pept 78, 31-39.
48. Rehfeld, J.F. 1998b. The new biology of gastrointestinal hormones. Physiol Rev 78, 1087-1108.
49. Rehfeld, J.F. & Hansen, H.F. 1986. Characterization of preprocholecystokinin products in the porcine cerebral cortex. Evidence of different processing pathways. J Biol Chem 261, 5832-5840.
50. Rehfeld, J.F. & Johnsen, A.H. 1994. Identification of gastrin component I as gastrin-71. The largest possible bioactive progastrin product. Eur J Biochem 223, 765-773.
51. Rehfeld, J.F. & Stadil, F. 1973. The effect of gastrin on basal- and glucose-stimulated insulin secretion in man. J Clin Invest 52, 1415-1426.
52. Rehfeld, J.F., Lauritsen, K.B. & Stadil, F. 1976. Insulin secretion in the Zollinger-Ellison syndrome. Scand J Gastroenterol Suppl 37, 63-66.
53. Rehfeld, J.F., Holst, J.J. & Kuhl, C. 1978. The effect of gastrin on basal and aminoacid-stimulated insulin and glucagon secretion in man. Eur J Clin Invest 8, 5-9.
54. Rehfeld, J.F., Larsson, L.I., Goltermann, N.R., Schwartz, T.W., Holst, J.J., Jensen, S.L. & Morley, J.S. 1980. Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK. Nature 284, 33-38.
55. Rehfeld, J.F., Hansen, C.P. & Johnsen, A.H. 1995. Post-poly(Glu) cleavage and degradation modified by O-sulfated tyrosine: a novel post-translational processing mechanism. EMBO J 14, 389-396.
56. Rehfeld, J.F., Sun, G., Christensen, T. & Hillingso, J.G. 2001. The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. J Clin Endocrinol Metab 86, 251-258.
57. Rehfeld, J.F., Friis-Hansen, L., Goetze, J.P. & Hansen, T.V. 2007. The biology of cholecystokinin and gastrin peptides. Curr Top Med Chem 7, 1154-1165.
58. Rehfeld, J.F., Bundgaard, J.R., Hannibal, J., Zhu, X., Norrbom, C., Steiner, D.F. & Friis-Hansen, L. 2008. The cell-specific pattern of cholecystokinin peptides in endocrine cells versus neurons is governed by the expression of prohormone convertases 1/3, 2, and 5/6. Endocrinology 149, 1600-1608.
59. Reubi, J.C. 2003. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 24, 389-427.
60. Reubi, J.C., Schaer, J.C. & Waser, B. 1997. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res 57, 1377-1386.
61. Reubi, J.C., Waser, B., Gugger, M., Friess, H., Kleeff, J., Kayed, H., Buchler, M.W. & Laissue, J.A. 2003. Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue. Gastroenterology 125, 98-106.
62. Rooman, I. & Bouwens, L. 2004. Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan. Diabetologia 47, 259-265.
63. Rooman, I., Lardon, J. & Bouwens, L. 2002. Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue. Diabetes 51, 686-690.
64. Saillan-Barreau, C., Dufresne, M., Clerc, P., Sanchez, D., Corominola, H., Moriscot, C., Guy-Crotte, O., Escrieut, C., Vaysse, N., Gomis, R., Tarasova, N. & Fourmy, D. 1999. Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas. Diabetes 48, 2015-2021.
65. Schmitz, F., Goke, M.N., Otte, J.M., Schrader, H., Reimann, B., Kruse, M.L., Siegel, E.G., Peters, J., Herzig, K.H., Folsch, U.R. & Schmidt, W.E. 2001. Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosa. Regul Pept 102, 101-110.
66. Starling, E.H. 1905. The Croonian Lectures on the chemical correlation of the functions of the body. Lancet 2, 339-583.
67. Suarez-Pinzon, W.L., Yan, Y., Power, R., Brand, S.J. & Rabinovitch, A. 2005. Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice. Diabetes 54, 2596-2601.
68. Suarez-Pinzon, W.L., Power, R.F., Yan, Y., Wasserfall, C., Atkinson, M. & Rabinovitch, A. 2008. Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice. Diabetes 57, 3281-3288.
69. Wang, T.C., Bonner-Weir, S., Oates, P.S., Chulak, M., Simon, B., Merlino, G.T., Schmidt, E.V. & Brand, S.J. 1993. Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells. J Clin Invest 92, 1349-1356.
70. Wang, R.N., Rehfeld, J.F., Nielsen, F.C. & Kloppel, G. 1997. Expression of gastrin and transforming growth factor-alpha during duct to islet cell differentiation in the pancreas of duct-ligated adult rats. Diabetologia 40, 887-893.
71. Wank, S.A. 1995. Cholecystokinin receptors. Am J Physiol 269, G628-G646.
72. Wank, S.A., Harkins, R., Jensen, R.T., Shapira, H., de, W.A. & Slattery, T. 1992. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci USA 89, 3125-3129.
73. You, Z.B., Herrera-Marschitz, M., Pettersson, E., Nylander, I., Goiny, M., Shou, H.Z., Kehr, J., Godukhin, O., Hokfelt, T., Terenius, L. & Ungerstedt, U. 1996. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity. Neuroscience 74, 793-804.